March 16, 2018 5:48pm

“Double, double toil and trouble, fire burn and cauldron bubble" - Macbeth  

 

The sector opened down, jumped at the 10:30 a.m. mark, hit the mid-day neutral and closed to the upside

Remember, the broomstick has its origins in hallucinogenic plant pharmacology as popularized by Shakespeare

 

Q4 and FY17 financial results: Stemline Therapeutics (STML) reported a Q4 loss of -$21.7 million with a per share loss of -$0.93. For FY17, STML reported a widening loss of $67.8 million, or $2.94 per share. STML’s shares have decreased 4% since 1/2/17, and have climbed 53 % in the last 12 months.

Interpretation, insight and translation with an end-of-day recap of the sessions impact, settlement with an opinion of what could or should happen next thrown in.

 

A reminded, we always need to end the week with some humor or frivolity as I marinate some white onions in a distilled beverage or two 

 

I make a commitment to provide need-to-know “facts in evidence” as equity’s volatility is one tactical signal for stocks.

 

Henry’omics:

From the pre-open’s newsletter, “…up the wall of worry, down the slippery slope … today marks quadruple-witching day and quadruple-witching hour; on quadruple witching days, and especially during quadruple witching hours, many attempt to unwind their futures and options positions before the contracts expire. This activity frequently includes repurchasing contracts and closing out positions.”

Reiterating, as a bluebird bio (BLUE -$14.85) upside “denier” - that is one who thinks it’s time for a decline – I am validated - AGAIN, sticking to MY thesis.

One of the multiple factors, I use is volume, which displays the number of shares that have been traded during a session by day, week and month, focusing on the advance/decline lines (A/DL)a way to assess the significance of changes in a security’s price.

Volume has picked-up on Friday …

Today levels the playing field – I hope … as many covering and cleaned-up their future positions!

 

The advance/decline line scenario of 40 covered companies:   

  • The open was negative with the A/DL to 11/25 and 4 flats;
  • 10:30 a.m. was positive with an A/DL of 21/15 and 4 flats;
  • The mid-day was neutral with an A/DL of 18/18 and 4 flats;
  • The close was positive with an A/DL of 23/17 and 0 flat;

 

 

MY working trend lines:

… The greatest volume to the downside:  SGMO, BLUE, ADVM, STML and ADRO

… Upside volume was weighted to:  MDXG, XON, BTX, FCSC and IMUC

… Biggest $ downside:  BLUE (-$14.85), RENE.L (-$4.50), CLLS (-$1.44), STML (-$0.95) and SGMO (-$0.75)

… Largest $ upside: ONCE (+$2.61), AXGN (+$0.55), VCEL (+0.35), XON (+$0.26) and BTX (0.25)

… Flat:  NONE

 

 

Daily analytics:

U.S. stocks closed slightly higher on Friday, as a round of positive economic data overshadowed ongoing political uncertainty, though major indexes posted sharp declines for the week.

  • The Dow rose 58 points, or 0.2%, to 24,932.
  • The S&P 500 added 4 points, or 0.1%, to 2,751, ending higher for its first day this week.
  • The NASDAQ rose less than 1 point to 7,482.

 

The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market,

  • Friday traded at 15.80, down -4.76% …
  • Thursday traded at 16.59, down -3.71%
  • Wednesday traded at 17.23, up +5.38%
  • Tuesday traded at 16.43, up +4.12%
  • Monday traded 15.78, up +78.79%
  • Last Friday traded at 14.64, down -11.49%

 

The iShares Russell 2000 (IWM) indicated:

  • Friday was up +0.53%
  • Thursday -0.49%
  • Wednesday -0.46%
  • Tuesday -0.43%
  • Monday +0.18%
  • Last Friday +1.57%

 

The iShares NASDAQ Biotechnology (IBB) indicated:

  • Friday was up +0.06%
  • Thursday -0.98%
  • Wednesday -0.12%
  • Tuesday -0.71%
  • Monday +0.32%
  • Last Friday +1.55%

 

 

The count - decliners versus gainers:

……. look at the differences in decliners:

  • Friday’s decliners ranged from -0.34% < FATE -$0.04> to -6.92% <BLUE -$14.85> in 17 equities;
  • Thursday’s decliners ranged from -0-.28% < CLLS -$0.10> to -9.35% <IMUC -$0.026 > in 27 equities;
  • Wednesday’s decliners ranged from -0.15% <RGNX -$0.05> to -11.42% <IMUC -$0.036> in 21 equities;
  • Tuesday’s decliners ranged from -0.62% <NWBO -$0.00> to -4.16% <BLUE -$9.70> in 16 equities;
  • Monday’s decliners ranged from -0.30% <MESO -$02> to -3.03% <VCEL -$0.35> in 21 equities;
  • Last Friday’s decliners ranged from -0.74% <BTX -$0.02> to -7.22% <AGTC -$0.35> in 17 equities;

Versus

… Look at the percentage’s (%) and spreads …

  • Friday’s gainers ranged from +0.12% <NWBO +$0.0004> to +11.48% <FCSC +0.07> in 23 equities;
  • Thursday’s gainers ranged from +0.31% <NWBO +0.001> to +7.02% <FCSC +$0.04> in 11 equities;
  • Wednesday’s gainers ranged from +0.60% <VSTM +$0.02> to +11.18% <CLLS +3.54> in 18 equities;
  • Tuesday’s gainers ranged from +0.62% <CYTX +$0.002> to +2.03% <AXGN +$0.70> in 19 equities;
  • Monday’s gainers ranged from +0.47% <BLUE +$1.10> to +3.43% <ADRO +$0.30> in 16 equities;
  • Last Friday’s gainers ranged from +0.65% <ISCO +$0.01> to +10.76% <ADRO +$0.85> in 21 equities;

 

                                  

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.